Similar articles

• [On the current debate on lowering LDL cholesterol with ezetimibe].

  Breuer HW. Breuer HW. Dtsch Med Wochenschr. 2010 Nov;135(44):2201; author reply 2202. doi: 10.1055/s-0030-1267499. Epub 2010 Oct 26. Dtsch Med Wochenschr. 2010. PMID: 20979008 German. No abstract available.
• ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].

  Olsson AG, Nilsson PM. Olsson AG, et al. Lakartidningen. 2009 Mar 18-24;106(12):854-7. Lakartidningen. 2009. PMID: 19452786 Review. Swedish. No abstract available.
• [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].

  Weizel A, Sawicki PT. Weizel A, et al. MMW Fortschr Med. 2004 Dec 16;146(51-52):14, 16. MMW Fortschr Med. 2004. PMID: 15675236 German. No abstract available.
• Lipid management with statins. The lower the better?

  Laufs U, Liao JK, Böhm M. Laufs U, et al. Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y. Z Kardiol. 2004. PMID: 14740235 Review.
• Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.

  Bruckert E, Giral P, Tellier P. Bruckert E, et al. Circulation. 2003 Jul 1;107(25):3124-8. doi: 10.1161/01.CIR.0000072345.98581.24. Circulation. 2003. PMID: 12835406 Review. No abstract available.